| No preoperative IABP | Preoperative IABP | Pvalue |
---|---|---|---|
(n = 203) | (n = 203) | ||
Age (years) | 66.0 (59.0, 74.0) | 65.0 (57.0, 74.0) | 0.514 |
Female | 59 (29.1%) | 47 (23.2%) | 0.175 |
Body mass index | 27.6 (24.2, 30.4) | 26.9 (24.6, 30.5) | 0.716 |
Cerebrovascular disease | 32 (15.8%) | 35 (17.2%) | 0.688 |
Peripheral vascular disease | 28 (13.8%) | 24 (11.8%) | 0.553 |
Diabetes | 87 (42.9%) | 103 (50.7%) | 0.112 |
Congestive heart failure | 55 (27.1%) | 60 (29.6%) | 0.582 |
Dialysis | 8 (3.9%) | 6 (3.0%) | 0.587 |
Preoperative creatinine | 1.00 (0.90, 1.30) | 1.00 (0.90, 1.30) | 0.953 |
Chronic obstructive pulmonary disease | 69 (34.0%) | 72 (35.5%) | 0.755 |
Hypercholesterolemia | 74 (36.5%) | 75 (37.0%) | 0.918 |
Hypertension | 156 (76.9%) | 158 (77.8%) | 0.812 |
Ejection fraction (%) | 40 (30, 50) | 40 (30, 50) | 0.914 |
Prior cardiac operation | 5 (2.5%) | 3 (1.5%) | 0.475 |
Preoperative anticoagulation | 167 (82.3%) | 168 (82.8%) | 0.896 |
Preoperative antiplatelet | 54 (26.6%) | 54 (26.6%) | 1.000 |
Preoperative intravenous nitroglycerin | 28 (13.8%) | 29 (14.3%) | 0.886 |
Operative status | Â | Â | Â |
Elective/Urgent | 197 (97.0%) | 190 (93.6%) | 0.100 |
Emergent | 6 (3.0%) | 13 (6.4%) | Â |
Preoperative myocardial infarction | Â | Â | Â |
<6 hrs | 1 (0.5%) | 0 (0.0%) | Â |
<24 hrs | 10 (4.9%) | 11 (5.4%) | 0.930 |
1-7 days | 171 (84.2%) | 172 (84.7%) | Â |
8-21 days | 22 (10.8%) | 20 (9.9%) | Â |
Preoperative hemodynamic instability | 9 (4.4%) | 8 (3.9%) | 0.804 |
Vessels diseased | Â | Â | Â |
Left circumflex artery | 148 (72.9%) | 148 (72.9%) | 1.000 |
Right coronary artery | 144 (70.9%) | 157 (77.3%) | 0.141 |
Left anterior descending | 171 (84.2%) | 170 (83.7%) | 0.892 |
Left main coronary artery | 65 (32.0%) | 59 (29.1%) | 0.518 |
Triple-vessel disease | 104 (51.2%) | 113 (55.7%) | 0.371 |
Modified STS mortality risk | 2.1% (1.1, 5.2) | 1.9 (1.0, 4.1) | 0.354 |
Modified STS morbidity/mortality risk | 18.8% (10.7, 31.4) | 18.1% (11.1, 27.2) | 0.350 |